Target Price Maintained at 230,000 Won

On April 1, Yuanta Securities maintained its "Buy" investment rating and target price of 230,000 won for Cosmax.


Seungeun Lee, a researcher at Yuanta Securities, stated, "In the short term, there are factors such as weakened profitability due to a shift in product mix and sluggish performance in certain regions. However, the trend of expanding global orders, particularly led by the U.S. subsidiary, continues." Lee added, "The mid- to long-term growth trajectory remains valid."


The shift in product mix refers to expanding the skincare portfolio instead of color cosmetics. Lee explained that sales of color cosmetics are declining, and this shift toward skincare-focused products is negatively affecting margins in the short term. As a result, the operating profit margin is expected to decline by 0.3 percentage points year-on-year.

[Click e-Stock] "Cosmax Faces Short-Term Profitability Slowdown Due to Product Mix Shift" View original image

Although the unit margin for skincare is higher, previous color cosmetics sales were concentrated in large-volume products, leading to higher fixed cost efficiency. In contrast, the recent growth in skincare sales is more dispersed in volume and has a different pricing structure, which means it does not contribute to profits at the same level as before, according to Lee.



Meanwhile, Lee pointed out that naphtha supply and demand issues could be a cost burden factor in the mid- to long-term. However, Lee said, "The company pre-purchases raw materials and maintains inventory for a certain period, so the short-term impact is expected to be limited."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing